After decades of decline, rates of cervical cancer within Canada have plateaued, according to the Canadian Cancer Society — a ...

Nuvalent has reported phase 1/2 lung cancer data, teeing the biotech up to talk to the FDA about an approval filing that could establish its neladalkib as a challenger to Pfizer’s Lorbrena.

Artios Pharma is working on a pipeline of oncology assets, led by alnodesertib, currently being tested for second-line ...

Jazz Pharmaceuticals (NASDAQ:JAZZ) saw its stock soar 25% after unveiling encouraging Phase 3 results for its investigational ...

A new study suggests that eating large amounts of ultra-processed foods may increase the risk of developing precancerous ...

Patients with colon cancer using GLP-1 receptor agonists (the class of drugs behind treatments like Ozempic, Wegovy, and ...

The study sought to answer questions about how breast cancer risk differs by type of hormonal contraceptive. Doctors say the ...

According to data from the National Institute on Minority Health and Health Disparities, Louisiana had the eighth-highest ...

Zymeworks Inc. (NASDAQ:ZYME) saw its stock price soar 57% after unveiling encouraging topline findings from its Phase 3 ...

While past studies have explored how cancer patients' financial health influenced their risk of mortality, new research digs ...

Elimination is within reach — but Canada must act now to address gaps in cancer screening and increase HPV vaccination uptake ...

The Ontario Hereditary Cancer Research Network's (OHCRN) participant portal is now open and Ontarians at risk of hereditary cancers are invited to register.